Sree Chitra researchers develop technology to detect cancer-causing circulating tumor cells. A special kit can be used to look for circulating tumor cells (CTC) in a blood sample. CTC makes cancer worse and causes cancer to come back in people who have already beaten it. The Sree Chitra team has asked for money from the Indian Council of Medical Research to pay for a clinical trial.
- Researchers at Sree Chitra have developed a method for detecting cancer-inducing circulating tumor cells.
- New tumors are formed by cancer cells that move through the blood.
- A special kit can be used to look for circulating tumor cells (CTC) in a blood sample.
- The CTC makes cancer worse and causes cancer to come back in people who have recovered from their illness.
- The Sree Chitra team has asked for money from the Indian Council of Medical Research (ICMR) so that they can use this technology in a clinical trial.
- The method is used in the United States to find people who are more likely to get cancer that spreads.
Sree Chitra Tirunal Institute for Medical Sciences and Technology in Thiruvananthapuram has developed a way to detect metastasis, where cancer cells travel through the blood and form new tumors. This new technology can be used to look for metastasis. Researchers have found that a special kit can be used to look for circulating tumor cells (CTC) in a blood sample. There is a link between the CTC and cancer and cancer recurrence in people who have recovered from their illnesses.
He said that the most important thing about this is that it can detect the possibility of metastasis early on and get treatment.
Under the direction of Dr. Jayashree, K Jibin and V Ramesh Babu are working on the study.
ACS Sustainable Chemistry and Engineering is the journal where they were written about. They have asked for money from the Indian Council of Medical Research (1CMR) to do a clinical study with this technology.
The way is
People usually don’t have more than 5 CTC in 10mm blood, but this isn’t always the case. This low number makes it difficult to do tests. To get around this, a nanotag made of gold and graphene will be attached to the antibody that fights CTC. Filters can be used to separate this from the blood sample. It can be done this way to separate CTC from all the other things in the blood. Looking at the filter and graphene in microscopic detail, you can see if the CTC is there.
Because of these things, it’s worth it.
The “cell sense” method is used in the United States to determine if someone is at risk of getting cancer that spreads. New research has found a way to make even this easier. Also, there would be no need for surgery to bring tissues and tests. A liquid biopsy, which looks for signs of illness in blood samples, will be used instead.